Source: Virtual Congress 2021 – Biological and functional markers of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
A. Camelier (Salvador (BA), Brazil), A. Meireles (Salvador (BA), Brazil), A. Oliveira (Salvador (BA), Brazil), V. Araujo (Salvador (BA), Brazil), M. Santos (Salvador (BA), Brazil), L. Correia (Salvador (BA), Brazil). Late Breaking Abstract - Development of a multivariate model for clinical prediction in COVID 19 infected patients .. 3894

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Validation of a clinical score predictive of SARS-CoV-2 infection in pneumonia inpatients Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients. Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound Year: 2020 Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED). Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Late Breaking Abstract - Cluster analysis of treatable traits in the U-BIOPRED adult severe asthma cohort Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics Year: 2017 Late Breaking Abstract - Microsimulation model of future trends in CF burden and demography in France Source: International Congress 2018 – Paediatric respiratory infections: translational and clinical perspectives Year: 2018 Late Breaking Abstract - Reslizumab vs benralizumab in patients with inadequately controlled asthma: a Bayesian network meta-analysis Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Relevance of first wave derived COVID-19 prediction scores, in the UK second wave, for mortality and safe early discharge Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Late Breaking Abstract - Clinical, functional and radiological outcomes up to 12 months following COVID-19. Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Late Breaking Abstract - 12-month lung clinical and functional consequences in patients with severe COVID-19 Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021